Cathay Biotech (SHSE:688065) EV-to-Revenue : 11.96 (As of May. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cathay Biotech's enterprise value is ¥27,427 Mil. Cathay Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,293 Mil. Therefore, Cathay Biotech's EV-to-Revenue for today is 11.96.

The historical rank and industry rank for Cathay Biotech's EV-to-Revenue or its related term are showing as below:

SHSE:688065' s EV-to-Revenue Range Over the Past 10 Years
Min: 9.7 Med: 16.75 Max: 61.31
Current: 12.32

During the past 8 years, the highest EV-to-Revenue of Cathay Biotech was 61.31. The lowest was 9.70. And the median was 16.75.

SHSE:688065's EV-to-Revenue is ranked worse than
95.58% of 1537 companies
in the Chemicals industry
Industry Median: 1.61 vs SHSE:688065: 12.32

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Cathay Biotech's stock price is ¥53.38. Cathay Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.93. Therefore, Cathay Biotech's PS Ratio for today is 13.59.

Cathay Biotech EV-to-Revenue Historical Data

The historical data trend for Cathay Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech EV-to-Revenue Chart

Cathay Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

19.70

30.43

14.20

15.17

Cathay Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															15.50	16.37	14.85	15.17	11.36

Competitive Comparison of Cathay Biotech's EV-to-Revenue

For the Chemicals subindustry, Cathay Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cathay Biotech's EV-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cathay Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cathay Biotech's EV-to-Revenue falls into.

Cathay Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cathay Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	27426.982	/	2293.251
	=	11.96

Cathay Biotech's current Enterprise Value is ¥27,427 Mil.
Cathay Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,293 Mil.

Cathay Biotech (SHSE:688065) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cathay Biotech's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	53.38	/	3.928
	=	13.59

Cathay Biotech's share price for today is ¥53.38.
Cathay Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.93.

Cathay Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cathay Biotech (SHSE:688065) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

https://www.cathaybiotech.com

Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines